HERMES Medical Imaging suite that provides software application used to process, display, analyze and manage nuclear medical imaging data transferred from other workstation or acquisition stations.

Device Description

The Hermes Medical Imaging Suite provides software applications used to process, display, analyze and manage nuclear medicine and other medical imaging data transferred from other workstation or acquisition stations.

AI/ML Overview

The provided text describes a 510(k) submission for the Hermes Medical Imaging Suite v5.3. It focuses on the substantial equivalence of the new version to previously marketed predicate devices, primarily due to a change in the software's operating environment from Oracle® Solaris to Microsoft® Windows.

Although the document mentions "acceptance criteria" and "testing results supports that all the software specifications have met the acceptance criteria," it does not provide specific details on what these acceptance criteria were, what the reported device performance against those criteria was, or any clinical study details.

Therefore, many of the requested items cannot be extracted from this document.

Here's a breakdown of what can be inferred and what is explicitly missing:

1. A table of acceptance criteria and the reported device performance

Acceptance Criteria	Reported Device Performance
Not specified	Not specified

Explanation: The document states, "The testing results supports that all the software specifications have met the acceptance criteria." However, it does not define what those specifications or acceptance criteria were, nor does it provide any quantitative performance metrics. The testing was primarily focused on demonstrating that the transfer of NM-processing applications to a new operating environment maintained the same technological characteristics and intended use as the predicate devices.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

Sample Size (Test Set): Not specified.
Data Provenance: Not specified.

Explanation: The document focuses on technical verification and validation of software functionality after an operating environment change. It does not describe a clinical study involving a test set of patient data.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

Number of Experts: Not applicable, as no clinical test set for ground truth establishment is described.
Qualifications of Experts: Not applicable.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Adjudication Method: Not applicable.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

MRMC Study: No. This document describes a software update for an image processing system, not an AI-assisted diagnostic tool or a comparative effectiveness study involving human readers.
Effect Size: Not applicable.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Standalone Study: The document does not describe a standalone performance study in the context of an algorithm's diagnostic accuracy. The "testing" mentioned refers to verification and validation of software specifications, ensuring the functionality remained consistent after the platform migration.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

Type of Ground Truth: Not applicable, as the document does not describe a clinical study requiring ground truth for diagnostic accuracy. The testing was against design specifications and predicate device performance, not clinical ground truth.

8. The sample size for the training set

Sample Size (Training Set): Not applicable. This device is not described as an AI/ML device that requires a training set.

9. How the ground truth for the training set was established

Ground Truth Establishment (Training Set): Not applicable.

Summary of the Study described:

The study described in the 510(k) summary is a technical verification and validation study to demonstrate that the Hermes Medical Imaging Suite v5.3, with its NM-processing applications transferred from Oracle® Solaris to Microsoft® Windows, maintains the same technological characteristics and intended use as its predicate devices. The "testing" ensured that "all the software specifications have met the acceptance criteria," and "comparisons were made between HERMES Medical Imaging Suite v5.3 and HERMES Medical Imaging Workstation (K121278), HERMES HDAQ Acquisition Station and Hermes Workstation (K021656), HERMES HDAQ Acquisition Station and Hermes Workstation (K002782) and Xeleris 2 processing and review workstation (K051673). The results showed a good compliance."

This is a regulatory submission focused on demonstrating substantial equivalence for a software update rather than a clinical performance study with specific diagnostic accuracy metrics.

Summary

{0}------------------------------------------------

13/233

Page 1 of 2

5.0 510 (k) SUMMARY

JUL 1 6 2013

A. Submitted by:

Submitters name and address: . Hermes Medical Solutions AB Skeppsbron 44 111 30 Stockholm Sweden

Submitters telephone number .

+46 8 19 03 25 Phone: +46 708 19 03 08 Cell: +46 8 18 43 54 Fax: E-mail: joakim.arwidson@hermesmedical.com

. Contact person Joakim Arwidson Quality Manager Hermes Medical Solutions AB Skeppsbron 44 111 30 Stockholm
- Sweden
. Registration number 9710645
B. Preparation date:

2013-04-08

C. Proprietary/Trade name, Common name, Classification name:

Proprietary/Trade name . Hermes Medical Imaging Suite v5.3
. Common name Image processing systems
. Classification name Emission Computer Tomography System, Class II, 21CFR892.1200

D. Legally marketed device (predicate device):

Following legally marketed device has been used for comparison.

HERMES Medical Imaging Workstation (K121278) .
HERMES HDAQ Acquisition Station and Hermes Workstation (K021656) .
HERMES HDAQ Acquisition Station and Hermes Workstation (K002782) .
. Xeleris 2 processing and review workstation (K051673)

E. Description of the device that is subject of this premarket notification:

The base product design of Hermes Medical Imaging Suite v5.3 is the same as for the Hermes Medical Imaging Suite v5.2 (K121278). A modification has been made of the product where the NM-processing applications have been transferred from the Oracle® Solaris environment to the

{1}------------------------------------------------

Microsoft® Windows environment as described in the 510(k) submission. The Hermes Medical Imaging Suite provides software applications used to process, display, analyze and manage nuclear medicine and other medical imaging data transferred from other workstation or acquisition stations.

F. Intended use:

HERMES Medical Imaging suite that provides software applications used to process, display, analyze and manage nuclear medicine and other medical imaging data transferred from other workstation or acquisition stations.

G. Technological characteristics:

The proposed device Hermes Medical Imaging Suite has the same technological characteristics as the original device and the same indication for use, except that the NM processing applications have been transferred from the Oracle® Solaris environment to the Microsoft® Windows environment as described in the 510(k) submission.

H. Testing:

The tests for verification and validation followed Hermes Medical Solutions AB design controlled procedures. The Risk analysis was completed and risk control implemented to mitigate identified hazards. The testing results supports that all the software specifications have met the acceptance criteria.

I. Substantially Equivalent/Conclusions:

The proposed device HERMES Medical Imaging Suite v5.3 and the predicate devices HERMES Medical Imaging Suite v5.2 (K121278) have the same indication for use.

The proposed device will use similar technology and fundamental concepts and operation are also the same, as described in the 510(k) submission.

Comparisons were made between HERMES Medical Imaging Suite v5.3 and HERMES Medical Imaging Workstation (K121278), HERMES HDAQ Acquisition Station and Hermes Workstation (K021656), HERMES HDAQ Acquisition Station and Hermes Workstation (K002782) and Xeleris 2 processing and review workstation (K051673). The results showed a good compliance.

In summary, the HERMES Medical Imaging Suite v5.3 described in this submission is in our opinion substantially equivalent to the predicate devices.

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged in a circular fashion around the symbol. The text is in all caps and appears to be in a sans-serif font. The logo is black and white.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Pohlic Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-Golf Silver Spring, MD 20933-0002

July 16. 2013

Hermes Medical Solutions AB % Mr. Joakim Arwidson Quality Manger Skeppsbron 44 111 30 Stockholm SWEDEN

Re: K131233

Trade/Device Name: Hermes Medical Imaging Suite v5.3 Regulation Number: 21 CFR 892.1200 Regulation Name: Emission computed tomography system Regulatory Class: Il Product Code: KPS Dated: April 17. 2013 Received: May 06, 2013

Dear Mr. Arwidson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820): and if applicable. the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{3}------------------------------------------------

Page 2 - Mr. Arwidson

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638 2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/dcfault.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely vours.

Fara for

Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use

510(k) Number (if known): K131233

Device Name: HERMES Medical Imaging Workstation

Indications for Use:

HERMES Medical Imaging suite that provides software application used to process, display, analyze and manage nuclear medical imaging data transferred from other workstation or acquisition stations.

Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH. Office of In Vitro Diagnostics and Radiological Health (OIR)

Michael D. O'Hara

ivision Sien-Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health

510(k)

Page 1 of

Regulation Number and Section

§ 892.1200 Emission computed tomography system.

(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.